Jose Guerra-Valencia, MD
Psychiatry · South Miami, FLNPI 1154673770
Payments from drug & device makers
What this record shows
This record is dominated by other: $18,320 of the $18,320 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Neuronetics, Inc.. Among psychiatry clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1 payment — averaging $18,320 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuronetics, Inc.$18K
Across 2 payments — averaging $819,331 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$1.6M
What the payments were for
- Other$18,320100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuronetics, Inc. | 1 | $18,320 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROSTAR TMS THERAPY SYSTEM$18,320
How this compares
$18,320 in reported general payments places this provider in the 95th percentile of 2,059 psychiatry providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluphenazine Decanoate | 23 | $4,641 |
| Haloperidol | 64 | $4,624 |
| Fluphenazine Hcl | 54 | $3,462 |
| Aripiprazole | 17 | $3,111 |
| Perphenazine | 24 | $1,407 |
| Valproic AcidValproic Acid (As Sodium Salt) | 19 | $1,208 |
| Quetiapine Fumarate | 86 | $1,075 |
| Benztropine Mesylate | 58 | $983 |
| Divalproex Sodium ErDivalproex Sodium | 18 | $946 |
| Olanzapine | 18 | $597 |
| Mirtazapine | 21 | $546 |
| Buspirone Hcl | 24 | $379 |
| Hydroxyzine Pamoate | 17 | $335 |
| Risperidone | 14 | $249 |
| Memantine Hcl | 15 | $196 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in South Miami
- Andrew CutlerLakewood Ranch$5.7M
- Richard JacksonBoca Raton$3.6M
- Ilan MelnickCoral Gables$2.8M
- Todd BroderSt Augustine$1.6M
- Heather LuingSaint Augustine$1.5M
- Todd GatesWest Melbourne$1.2M
- Lawrence ReccoppaGainesville$968K
- Thomas ValenteLeesburg$967K
- Michelle ScargleClearwater$926K
- David SheehanTampa$631K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.